Irenic Comments on Teleflex’s Announcement That It Is Open to Strategic Alternatives

Calls on Board to Establish Strategic Review Sub-Committee with New Independent Directors to Oversee Process

NEW YORK–(BUSINESS WIRE)–Irenic Capital Management, LP, one of the largest shareholders of Teleflex Incorporated (“Teleflex” or the “Company”) (NYSE: TFX) with 2% ownership, today issued the following statement regarding the Company’s recent announcement:

“We welcome Teleflex’s newfound openness to consider all strategic alternatives.

As a next step, we believe the Board of Directors should form a Strategic Review sub-committee with new independent directors, including a shareholder representative and excluding Dr. Klasko, to work with its advisors to both engage with inbound approaches and solicit outbound interest — and report back to shareholders.

While we strongly disagree with the Board’s description of our conversation with Dr. Klasko, we look forward to working with the Board to take appropriate next steps to maximize value at Teleflex.”

About Irenic

Irenic Capital Management, LP is an investment management firm founded by Adam Katz and Andy Dodge. Based in New York City, Irenic works collaboratively with publicly traded companies to ensure operating activities, capital deployment and management incentives are all aligned to create value for the company and its owners. For more information about Irenic, please visit www.irenicmgmt.com.

Contacts

For Investors:
Jeff Shookus

Irenic Capital Management

[email protected]

For Media:
Longacre Square Partners

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.